Patents Assigned to I-MAB BIOPHARMA (HANGZHOU) CO., LTD.
  • Anti-GM-CSF antibodies and uses thereof
    Patent number: 11926662
    Abstract: Provided are anti-GM-CSF antibodies or fragments thereof including humanized antibodies and fragments. Also provided are uses of the antibodies and fragments for therapeutic, diagnostic and prognostic purposes. Therapeutic uses of the antibodies and fragments, for example include the treatment of inflammatory and autoimmune diseases and disorders.
    Type: Grant
    Filed: December 2, 2020
    Date of Patent: March 12, 2024
    Assignee: I-Mab Biopharma (Hangzhou) Co., Ltd.
    Inventors: Zhengyi Wang, Lei Fang, Bingshi Guo, Jingwu Zang
  • Anti-LAG-3 antibodies and uses thereof
    Patent number: 11414485
    Abstract: The present disclosure provides antibodies that bind Lymphocyte Activation Gene-3 (LAG-3). Also provided are methods of stimulating an immune response, inhibiting growth of tumor cells, and treating an autoimmune, inflammatory, or viral disease.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: August 16, 2022
    Assignee: I-MAB BIOPHARMA (HANGZHOU) CO., LTD.
    Inventors: Lei Fang, Zhengyi Wang, Bingshi Guo, Jingwu Zang, Wenqing Jiang, Yongqiang Wang